Evidence map›Paper›PMID 36120262›Full record

ArticleCureus2022

Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report.

Francisco Pombo, Carolina Seabra, Ana João Sá, Inês Ferreira

Abstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francisco PomboInternal Medicine, Centro Hospitalar do Tâmega e Sousa, Penafiel, PRT.
Carolina SeabraInternal Medicine, Centro Hospitalar do Tâmega e Sousa, Penafiel, PRT.
Ana João SáInternal Medicine, Centro Hospitalar do Tâmega e Sousa, Penafiel, PRT.
Inês FerreiraInternal Medicine, Centro Hospitalar do Tâmega e Sousa, Penafiel, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysgeusia is one of the most common side effects of chemotherapy. Still, there is little information given to patients and limited knowledge about its diagnosis and management. We report the case of a patient under a standard regimen of adjuvant chemotherapy treatment (cisplatin and vinorelbine) who developed a life-threatening case of diabetes mellitus decompensation (hyperosmolar hyperglycemic state) resulting from extreme dietary intake due to severe dysgeusia and polydipsia. Dysgeusia is associated with a wide range of chemotherapy drugs. It is a frequent side effect but often overlooked. Self-care strategies and pharmacological agents can be implemented to help ensure better compliance to cancer treatment and improve quality of life.

Indexed as

chemotherapydiabetes mellitusdysgeusiapolydipsiaquality of life

Identifiers

PMID36120262
PMCPMC9467480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.